Extracellular vesicle transfer from mesenchymal stromal cells modulates macrophage function in acute lung injury basic science and clinical implications

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 10, 2017, Pages 1234-1236

  Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; BIOLOGICAL MARKER; CD206 ANTIGEN; CONNEXIN 43; HERMES ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; LIPOXIN A; LYMPHOCYTE ANTIGEN; MESSENGER RNA; PEPTIDES AND PROTEINS; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS STIMULATED GENE 6 PROTEIN; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; AEROBIC METABOLISM; CELL THERAPY; CYTOKINE PRODUCTION; EDITORIAL; EVIDENCE BASED PRACTICE; EXOSOME; HUMAN; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; MESENCHYMAL STROMA CELL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; MACROPHAGE; MESENCHYMAL STEM CELL TRANSPLANTATION;

ACUTE LUNG INJURY; EXTRACELLULAR VESICLES; HUMANS; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS;

EID: 85034752883     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201706-1122ED     Document Type: Editorial

References (17)

1. Matthay MA, Pati S, Lee JW. Concise review: mesenchymal stem (stromal) cells: biology and preclinical evidence for therapeutic potential for organ dysfunction following trauma or sepsis. Stem Cells 2017; 35:316-324.
2. Morrison TJ, Jackson MV, Cunningham EK, Kissenpfennig A, McAuley DF, O'Kane CM, Krasnodembskaya AD. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med 2017; 196:1275-1286.
3. Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S, Bhattacharya J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012; 18:759-765.
4. Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, Stolz DB, Watkins SC, Di YP, Leikauf GD, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun 2015; 6:8472.
5. Jackson MV, Morrison TJ, Doherty DF, McAuley DF, Matthay MA, Kissenpfennig A, O'Kane CM, Krasnodembskaya AD. Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells 2016; 34: 2210-2223.
6. Gennai S, Monsel A, Hao Q, Park J, Matthay MA, Lee JW. Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Transplant 2015; 15:2404-2412.
7. Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A, Qu JM, Matthay MA, Lee JW. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 2014; 32:116-125.
8. Monsel A, Zhu YG, Gennai S, Hao Q, Hu S, Rouby JJ, Rosenzwajg M, Matthay MA, Lee JW. Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med 2015; 192:324-336.
9. Kourembanas S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol 2015; 77: 13-27.
10. Willis GR, Fernandez-Gonzalez A, Vitali SH, Liu X, Mitsialis SA, Kourembanas S. Mesenchymal stem cell exosome treatment restores lung architecture and ameliorates pulmonary hypertension associated with bronchopulmonary dysplasia [abstract]. Am J Respir Crit Care Med 2017; 195:A4934.
11. Zhou Y, Xu H, Xu W, Wang B, Wu H, Tao Y, Zhang B, Wang M, Mao F, Yan Y, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 2013; 4:34.
12. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010; 78:838-848.
13. Kim DK, Nishida H, An SY, Shetty AK, Bartosh TJ, Prockop DJ. Chromatographically isolated CD631CD811 extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI. Proc Natl Acad Sci USA 2016; 113:170-175.
14. Laffey JG, Matthay MA. Fifty years of research in ARDS: cell-based therapy for ARDS: biology and potential therapeutic value. Am J Respir Crit Care Med [online ahead of print] 17 Mar 2017; DOI: 10.1164/rccm.201701-0107CP.
15. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15:42-49.
16. Hayes M, Curley GF, Masterson C, Devaney J, O'Toole D, Laffey JG. Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury. Intensive Care Med Exp 2015; 3:29.
17. O'Reilly M, Thébaud B. Cell-based therapies for neonatal lung disease. Cell Tissue Res 2017; 367:737-745.